This new agent, like the other DPP-4 inhibitors, has a mechanism of action that affects both pancreatic ß-cell survival as well as ß-cell secretory function. These medications do not incite ...

Dipeptidyl peptidase-4 (DPP-4) inhibitors, commonly used to treat high blood glucose, have also shown efficacy against low blood sugar levels in a recent study. Results from this study have been ...

DPP-4 inhibitors help lower blood sugar levels ... Pioglitazone (Actos) is an example of a thiazolidinedione. Thiazolidinediones may increase the risk of heart problems in some people.

Back to Healio Unlike traditional oral diabetes medications, DDP-IV inhibitors have been associated ... the reduction in cardiac events. For example, DPP-IV inhibition increases the levels of ...

With previous research showing treatment with SGLT-2 inhibitors was associated with a greater reduction in the risk for dementia than DPP-4 treatment among people older than 66 years with type 2 ...

SGLT-2 inhibitor use vs DPP-4 inhibitor use was associated with lower incidence of epilepsy among patients with type 2 diabetes.

Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Dipeptidyl Peptidase IV (DPP-4) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast - 2034" report has been added to ...

In the present study, the researchers compared the impact of two antiglycemic drugs, SGLT-2 inhibitors and DPP-4 inhibitors, on dementia risk in individuals with type 2 diabetes. While SGLT-2 ...

DPP-IV inhibitor use declined from 62.4% in 2018 ... and other DPP-IV inhibitors may be still preferred in older and multimorbid patients at higher risk of frailty; for example, in the setting ...

is associated with a modestly lower risk for depression compared with dipeptidyl peptidase-4 inhibitor (DPP-4i) use, ...